2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版)

2021-12-13 法国放射肿瘤学学会 Cancer Radiother

2021年12月,法国放射肿瘤学学会(SFRO)发布了体外放射治疗和近距离放射治疗指南第3版,指南主要介绍了体外放射治疗和近距离放射治疗的一般原则和主要癌症的体外放射治疗和近距离放射治疗。

中文标题:

2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版)

英文标题:

Guidelines for external radiotherapy and brachytherapy procedures: 3rd edition

发布机构:

法国放射肿瘤学学会

发布日期:

2021-12-13

简要介绍:

2021年12月,法国放射肿瘤学学会(SFRO)发布了体外放射治疗和近距离放射治疗指南第3版,指南主要介绍了体外放射治疗和近距离放射治疗的一般原则和主要癌症的体外放射治疗和近距离放射治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=3a5c21c0023129f2, title=2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版), enTitle=Guidelines for external radiotherapy and brachytherapy procedures: 3rd edition, guiderFrom=Cancer Radiother, authorId=0, author=, summary=2021年12月,法国放射肿瘤学学会(SFRO)发布了体外放射治疗和近距离放射治疗指南第3版,指南主要介绍了体外放射治疗和近距离放射治疗的一般原则和主要癌症的体外放射治疗和近距离放射治疗。, cover=https://img.medsci.cn/202216/1641437883280_1608702.jpg, journalId=0, articlesId=null, associationId=2275, associationName=法国放射肿瘤学学会, associationIntro=法国放射肿瘤学学会(SFRO,French society for radiation oncology), copyright=0, guiderPublishedTime=Mon Dec 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月,法国放射肿瘤学学会(SFRO)发布了体外放射治疗和近距离放射治疗指南第3版,指南主要介绍了体外放射治疗和近距离放射治疗的一般原则和主要癌症的体外放射治疗和近距离放射治疗。</span></p>, tagList=[TagDto(tagId=80326, tagName=体外放射治疗), TagDto(tagId=81800, tagName=近距离放射治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=81800, guiderKeyword=近距离放射治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3623, appHits=54, showAppHits=0, pcHits=202, showPcHits=3569, likes=0, shares=11, comments=5, approvalStatus=1, publishedTime=Thu Jan 06 10:48:58 CST 2022, publishedTimeString=2021-12-13, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Jan 06 10:55:03 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Mon Jan 01 14:31:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版).pdf)])
2021 SFRO指南:体外放射治疗和近距离放射治疗(第3版).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203509, encodeId=6f5b120350985, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Thu Mar 17 17:12:57 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182431, encodeId=c448118243111, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:24:22 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181741, encodeId=80df1181e41ee, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f066452327, createdName=ms3000000924506497, createdTime=Fri Jan 07 09:14:02 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181376, encodeId=20ae11813e6bb, content=哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:22:30 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-03-17 cycy_20070101

    认真学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203509, encodeId=6f5b120350985, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Thu Mar 17 17:12:57 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182431, encodeId=c448118243111, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:24:22 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181741, encodeId=80df1181e41ee, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f066452327, createdName=ms3000000924506497, createdTime=Fri Jan 07 09:14:02 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181376, encodeId=20ae11813e6bb, content=哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:22:30 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-09 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203509, encodeId=6f5b120350985, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Thu Mar 17 17:12:57 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182431, encodeId=c448118243111, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:24:22 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181741, encodeId=80df1181e41ee, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f066452327, createdName=ms3000000924506497, createdTime=Fri Jan 07 09:14:02 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181376, encodeId=20ae11813e6bb, content=哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:22:30 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-07 ms3000000924506497

    好东西

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203509, encodeId=6f5b120350985, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Thu Mar 17 17:12:57 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182431, encodeId=c448118243111, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:24:22 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181741, encodeId=80df1181e41ee, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f066452327, createdName=ms3000000924506497, createdTime=Fri Jan 07 09:14:02 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181376, encodeId=20ae11813e6bb, content=哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:22:30 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-06 ms5000000224637601

    0

拓展阅读

2017 ACR/ABS实践参数:低剂量率近距离放射治疗的性能

美国放射学会(ACR,American College of Radiology) · 2017-01-15

2021 SFRO指南:前列腺癌近距离放射治疗

法国放射肿瘤学学会(SFRO,French society for radiation oncology) · 2021-12-22

JASTRO共识指南:妇科肿瘤腔内和间质联合近距离放射治疗

日本放射肿瘤学协会(JASTRO,Japanese Society for Radiation Oncology) · 2022-03-28

2022 ABS共识声明:肝脏肿瘤钇90微球永久性植入近距离放射治疗

美国近距离放疗学会(ABS,American Brachytherapy Society) · 2022-05-19

2022 SAR/ABS共识建议:当代影像引导宫颈癌近距离放射治疗

美国近距离放疗学会(ABS,American Brachytherapy Society) · 2022-06-17